July 2019 Briefing – Cardiology
Medical Health News,
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for July 2019.
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for July 2019.
Patients with atrial fibrillation (AF) and a history of liver disease who are receiving oral anticoagulation have an increased…
Patients with atrial fibrillation (AF) and a history of liver disease who are receiving oral anticoagulation have an increased…
Arman Qamar Major bleeding risk was elevated in patients with atrial fibrillation and a history of liver disease after the use…
Arman Qamar Major bleeding risk was elevated in patients with atrial fibrillation and a history of liver disease after the use…
(HealthDay News) -- For patients with atrial fibrillation (AF), the efficacy and safety of edoxaban versus warfarin is not…
For patients with atrial fibrillation, the efficacy and safety of edoxaban versus warfarin is not altered with a history of…
(HealthDay)—For patients with atrial fibrillation (AF), the efficacy and safety of edoxaban versus warfarin is not altered with…
-- For patients with atrial fibrillation (AF), the efficacy and safety of edoxaban versus warfarin is not altered with a…